Abstrakt
Healthy first-degree relatives of patients with major depression (rMD+) show brain structure and functional response anomalies and have elevated risk for developing depression, a disorder linked to abnormal serotonergic neurotransmission and reward processing. Method In a two-step functional magnetic resonance imaging (fMRI) investigation, we first evaluated whether positive and negative monetary outcomes were differentially processed by rMD+ individuals compared to healthy first-degree relatives of control probands (rMD-). Second, in a double-blinded placebo-controlled randomized trial we investigated whether a 4-week intervention with the selective serotonergic reuptake inhibitor (SSRI) escitalopram had a normalizing effect on behavior and brain responses of the rMD+ individuals.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Psychological Medicine |
Vol/bind | 44 |
Udgave nummer | 6 |
Sider (fra-til) | 1183-1195 |
ISSN | 0033-2917 |
DOI | |
Status | Udgivet - apr. 2014 |